Development of a novel clinical biomarker assay to detect and quantify aggrecanase-generated aggrecan fragments in human synovial fluid, serum and urine

Osteoarthritis and Cartilage
C A SwearingenK Thirunavukkarasu

Abstract

Proteolytic degradation of aggrecan in articular cartilage is a hallmark feature of osteoarthritis (OA). The present study was aimed at developing a sensitive enzyme linked immunosorbent assay (ELISA) for the detection of aggrecanase-cleaved fragments of aggrecan in human serum and urine to facilitate the clinical development of aggrecanase inhibitors for OA. The BC3 monoclonal antibody that detects the ARGS neoepitope sequence in aggrecanase-cleaved aggrecan was engineered and optimized using complementarity determining region (CDR)-saturation mutagenesis to improve its binding affinity to the neoepitope. A sandwich ELISA (BC3-C2 ELISA) was developed using the optimized alpha-ARGS antibody (BC3-C2) as capture antibody and a commercially available antibody directed against the hyaluronic-acid binding region (HABR) of aggrecan as detection antibody. Aggrecanase-cleaved fragments of aggrecan present in in vitro digests, human cartilage explant culture supernatants and in human synovial fluid, serum and urine were detected and quantified using this ELISA. The optimized antibody had a 4-log improvement in affinity for the ARGS containing peptide compared to the parental BC3 antibody, while maintaining the ability to not cross-react...Continue Reading

References

Apr 20, 1989·Journal of Molecular Biology·S J PerkinsT E Hardingham
May 13, 1997·Proceedings of the National Academy of Sciences of the United States of America·J Hanes, A Plückthun
Jun 1, 1997·Nature Biotechnology·E T Boder, K D Wittrup
Apr 7, 2000·The Journal of Biological Chemistry·M D TortorellaE Arner
Apr 17, 2002·The Journal of Biological Chemistry·Anne-Marie MalfaitMicky D Tortorella
Aug 31, 2004·Arthritis and Rheumatism·Sonya S GlassonElisabeth A Morris
Apr 1, 2005·Nature·Heather StantonAmanda J Fosang
Apr 5, 2007·Nature Protocols·Ginger ChaoK Dane Wittrup
May 19, 2007·The Journal of Clinical Investigation·Christopher B LittleAmanda J Fosang
May 30, 2008·BMC Musculoskeletal Disorders·Jean C RousseauMorten A Karsdal

❮ Previous
Next ❯

Citations

Mar 5, 2011·Nature Protocols·Heather StantonAmanda J Fosang
Jul 2, 2011·Current Opinion in Rheumatology·Debabrata Patra, Linda J Sandell
Apr 28, 2012·Bone·J Ch Rousseau, P Garnero
Jan 24, 2012·Best Practice & Research. Clinical Rheumatology·Per QvistMorten A Karsdal
Jan 26, 2011·Drug Discovery Today·Frédéric De CeuninckPhilippe Pastoureau
Dec 24, 2013·Osteoarthritis and Cartilage·S LarssonA Struglics
Mar 4, 2014·Osteoarthritis and Cartilage·F M GermaschewskiN M Graham
Jul 15, 2015·Clinical Orthopaedics and Related Research·Justin M HallerThomas F Higgins
Jul 17, 2010·Osteoarthritis and Cartilage·A J Fosang, F M Rogerson
Feb 16, 2011·Osteoarthritis and Cartilage·V B Kraus
May 26, 2015·Biochimica Et Biophysica Acta·Anastasia SpyropoulouEfthimia K Basdra
Jun 15, 2017·Journal of Medicinal Chemistry·Timothy B DurhamMichael R Wiley
Jul 29, 2019·Molecular & Cellular Proteomics : MCP·Patricia Fernández-PuenteCristina Ruiz-Romero
Oct 8, 2016·Connective Tissue Research·James L CookBrandon L Roller
Aug 23, 2020·International Journal of Molecular Sciences·Anne Sofie SiebuhrSven Lindemann
Oct 1, 2019·Molecular & Cellular Proteomics : MCP·Patricia Fernández-PuenteCristina Ruiz-Romero

❮ Previous
Next ❯

Related Concepts

Related Feeds